Antiuveitis and inhibition of fibroblast-like corneal and conjunctival cell cultures by interleukin-1 blockers, CK 125, CK 126 and CK 128

Ophthalmic Research

Volumn 30, Issue 3, 1998, Pages 180-188

  Xuan, Bo ^a   Chiou, George C Y ^a   Yamasaki, Tetsuo ^b   Okawara, Tadashi ^b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antiuveitis; Conjunctival cells; Fibroblast like corneal cells; Incorporation of thymidine, uridine and leucine; Interleukin 1 blockers

Indexed keywords

4 ETHYL 5 [4 (2 METHYL 1 IMIDAZOLYL)BENZOYL] 2H IMIDAZOL 2 ONE; CK 125; CK 126; DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUCINE; MESSENGER RNA; PREDNISOLONE; THYMIDINE; UNCLASSIFIED DRUG; URIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA CELL; DNA SYNTHESIS; DRUG MECHANISM; DRUG POTENCY; FIBROBLAST; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; RNA SYNTHESIS; UVEITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL CULTURE TECHNIQUES; CELL DIVISION; CONJUNCTIVA; CORNEA; DNA; FIBROBLASTS; HYDRAZINES; INTERLEUKIN-1; LEUCINE; PREDNISOLONE; PYRIDAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER; THYMIDINE; URACIL; URIDINE; UVEITIS, POSTERIOR;

EID: 0031801460     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055472     Document Type: Article

References (15)

1. Patil PN, Burkman AM: Introduction to Ocular Pharmacology and Toxicology, chap 8. Greyden Press, 1996.
2. Chiou GCY, Chang MS: Ocular inflammation induced by lens protein and its prevention with new agents in Bazan NG (ed): New Trends in Lipid Mediators Research, Lipid Mediators in Eye Inflammation. Basel, Karger, 1990, pp 94-109.
3. Masuda K: Anti-inflammatory agents: Non-steroidal anti-inflammatory drugs in Sears ML (ed): Pharmacology of the Eye. New York, Springer, 1984, pp 539-551.
4. Braquet P: Handbook of PAF and PAT Antagonists. Boca Raton, CRC Press, 1991.
5. Melli M, Parente L: Cytokines and Lipocortins in Inflammation and Differentiation. New York, Wiley-Liss, 1990.
6. Dawson MM: Lymphokines and Interleukins. Boca Raton, CRC Press, 1991.
7. Granowitz EV, Porat R, Mier JW, Pribble JP, Stiles DM, Bloedow DC, Catalona MA, Wolff SM, Di-Narello CA: Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 1992;4:353-360.
8. Chiou GCY, Yao QS, Okawara T: Prevention of ocular inflammation induced by lens protein, endotoxin, and IL-1 blockers. J Ocular Pharmacol Ther 1994;10:577-586.
9. Chiou GCY, Yao QS, Chang MS, Okawara T: Prevention and treatment of ocular inflammation with a new class of non-steroidal anti-inflammatory agents. J Ocular Pharmacol Ther 1994;10:335-347.
10. Xiao JG, Schwade KD, Chiou GCY: Mechanisms of antagonism of interleukin-1α by synthetic interleukin-1 blockers. J Ocular Pharmacol Ther 1995;11:373-382.
11. Chiou GCY, Liu XL: Novel non-arachidonate-mediated, non-steroidal anti-inflammatory agents. Exp Opin Invest Drugs 1994;3:725-732
12. Chiou GCY, Chen Z, Xuan B, Yamasaki T, Okawara T: Antagonism of IL-1-induced uveitis with IL-1 blockers. J Ocular Pharmacol Ther, in press.
13. Schwade ND, Chiou GCY: The use of trabeculectomy to study the pharmacological modulation of ophthalmic wound healing. J Ocular Pharmacol Ther 1995;11:113-124.
14. Schwade ND, Chiou GCY: Effects of interleukin-1 blockers on ophthalmic wound healing in rabbit model of trabeculectomy. J Ocular Pharmacol Ther 1995;11:125-134.
15. Yamasaki T, Kawaminami E, Yamada T, Okamoto Y, Okawara T, Furukawa M: Novel heterocyclization of hydrazinopyridazinones with dimethyl acetylene-dicarboxylate with dehydrogenation and rearrangement. J Chem Soc Perkin Trans 1991;1:991.